This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Arrowood, M. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Arrowood, M. J.

 Previous Article  |  Next Article 

Clinical Microbiology Reviews, July 2002, p. 390-400, Vol. 15, No. 3
0893-8512/02/$04.00+0     DOI: 10.1128/CMR.15.3.390-400.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

In Vitro Cultivation of Cryptosporidium Species

Michael J. Arrowood*

Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Public Health Service, U.S. Department of Health and Human Services, Atlanta, Georgia 30341

The in vitro cultivation of protozoan parasites of the genus Cryptosporidium has advanced significantly in recent years. These obligate, intracellular parasites colonize the epithelium of the digestive and respiratory tracts, are often difficult to obtain in significant numbers, produce durable oocysts that defy conventional chemical disinfection methods, and are persistently infectious when stored at refrigerated temperatures (4 to 8°C). While continuous culture and efficient life cycle completion (oocyst production) have not yet been achieved in vitro, routine methods for parasite preparation and cell culture infection and assays for parasite life cycle development have been established. Parasite yields may be limited, but in vitro growth is sufficient to support a variety of research studies, including assessing potential drug therapies, evaluating oocyst disinfection methods, and characterizing life cycle stage development and differentiation.


* Mailing address: Division of Parasitic Diseases, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, GA 30341. Phone: (770) 488-4421. Fax: (770) 488-4253. E-mail: marrowood{at}cdc.gov.


Clinical Microbiology Reviews, July 2002, p. 390-400, Vol. 15, No. 3
0893-8512/02/$04.00+0     DOI: 10.1128/CMR.15.3.390-400.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:

  • Takeuchi, D., Jones, V. C., Kobayashi, M., Suzuki, F. (2008). Cooperative Role of Macrophages and Neutrophils in Host Antiprotozoan Resistance in Mice Acutely Infected with Cryptosporidium parvum. Infect. Immun. 76: 3657-3663 [Abstract] [Full Text]  
  • Rueda, C., Fenoy, S., Simon, F., del Aguila, C. (2008). Bobel-24 Activity against Cryptosporidium parvum in Cell Culture and in a SCID Mouse Model. Antimicrob. Agents Chemother. 52: 1150-1152 [Abstract] [Full Text]  
  • Sifuentes, L. Y., Di Giovanni, G. D. (2007). Aged HCT-8 Cell Monolayers Support Cryptosporidium parvum Infection. Appl. Environ. Microbiol. 73: 7548-7551 [Abstract] [Full Text]  
  • Feng, H., Nie, W., Sheoran, A., Zhang, Q., Tzipori, S. (2006). Bile Acids Enhance Invasiveness of Cryptosporidium spp. into Cultured Cells. Infect. Immun. 74: 3342-3346 [Abstract] [Full Text]  
  • Kjos, S. A., Jenkins, M., Okhuysen, P. C., Chappell, C. L. (2005). Evaluation of Recombinant Oocyst Protein CP41 for Detection of Cryptosporidium-Specific Antibodies. CVI 12: 268-272 [Abstract] [Full Text]  
  • Cai, X., Lancto, C. A., Abrahamsen, M. S., Zhu, G. (2004). Intron-containing {beta}-tubulin transcripts in Cryptosporidium parvum cultured in vitro. Microbiology 150: 1191-1195 [Abstract] [Full Text]